Pro football retirees are at least five times more likely to have atrial fibrillation than age- and race-matched male controls from the general population, finds a new cross-sectional study.
Atrial Arrhythmias in LVAD Recipients Don’t Compromise Outcomes in Large Cohort Study
A new study of over 400 patients with left ventricular assist devices adds to the mixed evidence on atrial arrhythmias in this population and provides the first systematic look at the effects of rhythm control.
Ablation of Atrial Fibrillation: Guidance for the Referring Physician
Our electrophysiologists share their approach to deciding between ablation and medical management along with a wealth of insights for care before and after the ablation procedure.
Ablation Vs. Medical Therapy for Atrial Fibrillation: Putting CABANA in Perspective
Debate around findings of the multicenter CABANA study of ablation versus drug therapy for atrial fibrillation shouldn’t distract from why patients seek ablation in the first place: symptom relief.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic Garners $3.7M AHA Award to Probe Atrial Fibrillation Prevention
Our funded projects include a study of interactions among genomics, aging and metabolism and a clinical trial of metformin and lifestyle modifications for reducing AF burden.
In LVAD Patients with Atrial Arrhythmias, Rhythm Control Offers Little Benefit
As the use of LVADs for destination therapy grows, a new study offers the first guidance on whether aggressive treatment for atrial arrhythmias makes a difference in this setting.
Genetic Control of Left Atrial Gene Expression: A New Window into AFib Risk
A new study identified genes and genetic variations associated with 12 loci linked to risk for atrial fibrillation. The result is a genome-wide catalog to facilitate follow-on investigations.
Ablation First for Atrial Fibrillation? Cleveland Clinic Cardiologist Looks to Shift Practice
Dr. Oussama Wazni suspects more patients with AF could benefit from early catheter ablation. So he’s leading two multicenter trials to see if his suspicions pan out.
Smartwatch Technology Detects Afib Prior to Cardioversion
A study shows that the first FDA-approved smartwatch healthcare accessory can effectively identify atrial fibrillation, especially with physician overview. But incorporating it into practice won’t be simple.
Atrial Fibrillation Prevalence Is Markedly Increased in NFL Retirees
Middle-aged pro football retirees have a 5.5 odds ratio of prevalent atrial fibrillation compared with matched nonathlete controls from the general population, a new study finds.